Literature DB >> 6326518

General properties of multiple molecular forms of cyclic nucleotide phosphodiesterase in the nervous system.

S J Strada, M W Martin, W J Thompson.   

Abstract

Mesh：

Substances：

Year:  1984        PMID： 6326518

Source DB:  PubMed          Journal:  Adv Cyclic Nucleotide Protein Phosphorylation Res        ISSN： 0747-7767


× No keyword cloud information.
  13 in total

Review 1.  Dysbalance of neuronal second messenger function in the aetiology of affective disorders: a pathophysiological concept hypothesising defects beyond first messenger receptors.

Authors:  H Wachtel
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

2.  Cyclic nucleotide phosphodiesterase and 5'-nucleotidase: a coupled system.

Authors:  A A Galoyan; N P Sharova
Journal:  Neurochem Res       Date:  1989-12       Impact factor: 3.996

Review 3.  Pharmacology of nootropics and metabolically active compounds in relation to their use in dementia.

Authors:  C D Nicholson
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

4.  Identification of a conserved domain among cyclic nucleotide phosphodiesterases from diverse species.

Authors:  H Charbonneau; N Beier; K A Walsh; J A Beavo
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

5.  The presence of five cyclic nucleotide phosphodiesterase isoenzyme activities in bovine tracheal smooth muscle and the functional effects of selective inhibitors.

Authors:  M Shahid; R G van Amsterdam; J de Boer; R E ten Berge; C D Nicholson; J Zaagsma
Journal:  Br J Pharmacol       Date:  1991-10       Impact factor: 8.739

6.  The ability of denbufylline to inhibit cyclic nucleotide phosphodiesterase and its affinity for adenosine receptors and the adenosine re-uptake site.

Authors:  C D Nicholson; S A Jackman; R Wilke
Journal:  Br J Pharmacol       Date:  1989-07       Impact factor: 8.739

7.  Effects of selective phosphodiesterase inhibition on cyclic AMP hydrolysis in rat cerebral cortical slices.

Authors:  R A Challiss; C D Nicholson
Journal:  Br J Pharmacol       Date:  1990-01       Impact factor: 8.739

8.  Evidence that the presynaptic A2a-adenosine receptor of the rat motor nerve endings is positively coupled to adenylate cyclase.

Authors:  P Correia-de-Sá; J A Ribeiro
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-11       Impact factor: 3.000

9.  Multiple actions of glaucine on cyclic nucleotide phosphodiesterases, alpha 1-adrenoceptor and benzothiazepine binding site at the calcium channel.

Authors:  M D Ivorra; C Lugnier; C Schott; M Catret; M A Noguera; E Anselmi; P D'Ocon
Journal:  Br J Pharmacol       Date:  1992-06       Impact factor: 8.739

10.  Potentiation of slow component of delayed rectifier K(+) current by cGMP via two distinct mechanisms: inhibition of phosphodiesterase 3 and activation of protein kinase G.

Authors:  Kentaro Shimizu; Yutaka Shintani; Wei-Guang Ding; Hiroshi Matsuura; Tadao Bamba
Journal:  Br J Pharmacol       Date:  2002-09       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.